Cardizem and Angioplasty - a phase IV clinical study of FDA data

Summary:

Angioplasty is found among people who take Cardizem, especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months.

The phase IV clinical study analyzes which people take Cardizem and have Angioplasty. It is created by eHealthMe based on reports of 26,148 people who have side effects when taking Cardizem from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 30, 2023

26,148 people reported to have side effects when taking Cardizem.
Among them, 38 people (0.15%) have Angioplasty.

What is Cardizem?

Cardizem has active ingredients of diltiazem hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 27,064 Cardizem users for its effectiveness, alternative drugs and more.

What is Angioplasty?

Angioplasty is found to be associated with 1,177 drugs and 670 conditions by eHealthMe.

Number of Cardizem and Angioplasty reports submitted per year:

Time on Cardizem when people have Angioplasty *:

Gender of people who have Angioplasty when taking Cardizem *:

female: 67.57 %
male: 32.43 %

Age of people who have Angioplasty when taking Cardizem *:

Common drugs people take besides Cardizem *:

Common side effects people have besides Angioplasty *:

Coronary Heart Disease (narrowing or blockage of the coronary arteries): 17 people, 44.74%
Cardiac Failure Congestive: 15 people, 39.47%
Peripheral Vascular Disorder: 13 people, 34.21%
Renal Failure Chronic (long lasting kidney dysfunction): 13 people, 34.21%
Infection: 11 people, 28.95%
Hypotension (abnormally low blood pressure): 11 people, 28.95%
Enlarged Heart: 11 people, 28.95%
Chest Pain: 10 people, 26.32%
Pleural Effusion (water on the lungs): 10 people, 26.32%
Ejection Fraction Decreased (systolic heart failure): 9 people, 23.68%

Common conditions people have *:

Hypercalcaemia (elevated calcium (ca+) level in the blood): 6 people, 15.79%
Multiple Myeloma (cancer of the plasma cells): 6 people, 15.79%
Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 6 people, 15.79%
Menopause (end of monthly cycles in women): 5 people, 13.16%
Thyroid Diseases: 5 people, 13.16%
Pain: 3 people, 7.89%
Joint Pain: 2 people, 5.26%
Irritable Bowel Syndrome: 2 people, 5.26%
Stable Angina (a constant chest pain): 2 people, 5.26%
Diabetes: 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Cardizem and have Angioplasty?

Check whether Angioplasty is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Angioplasty and when was it recovered:

Angioplasty in Cardizem

Expand to all the drugs that have ingredients of diltiazem hydrochloride:

Angioplasty and drugs with ingredients of diltiazem hydrochloride (73 reports)

Alternative drugs to, pros and cons of Cardizem:

Cardizem (27,064 reports)

Common Cardizem side effects:

Browse all side effects of Cardizem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Angioplasty treatments and more:

Angioplasty (5,334 reports)

COVID vaccines that are related to Angioplasty:

Common drugs associated with Angioplasty:

All the drugs that are associated with Angioplasty:

Angioplasty (1,177 drugs)

Common conditions associated with Angioplasty:

Diabetes: 362 reports
High blood pressure: 250 reports
High blood cholesterol: 179 reports
Primary pulmonary hypertension: 125 reports

All the conditions that are associated with Angioplasty:

Angioplasty (670 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on diltiazem hydrochloride (the active ingredients of Cardizem) and Cardizem (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.